hypoxic

BioRestorative Therapies Announces Completion of Human Safety and Feasibility Study on the Use of Hypoxic Cultured Stem Cells to Treat Chronic Lower Back Pain

MELVILLE, N.Y., June 28, 2016 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BRT” or the “Company”) (OTCBB:BRTX), a life sciences company…